NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States
dc.contributor.author | Marrero, Jorge A. | en_US |
dc.contributor.author | Fontana, Robert John | en_US |
dc.contributor.author | Su, Grace L. | en_US |
dc.contributor.author | Conjeevaram, Hari S. | en_US |
dc.contributor.author | Emick, Dawn M. | en_US |
dc.contributor.author | Lok, Anna Suk-Fong | en_US |
dc.date.accessioned | 2006-04-28T16:56:59Z | |
dc.date.available | 2006-04-28T16:56:59Z | |
dc.date.issued | 2002-12 | en_US |
dc.identifier.citation | Marrero, Jorge A.; Fontana, Robert J.; Su, Grace L.; Conjeevaram, Hari S.; Emick, Dawn M.; Lok, Anna S. (2002)."NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States." Hepatology 36(6): 1349-1354. <http://hdl.handle.net/2027.42/38413> | en_US |
dc.identifier.issn | 0270-9139 | en_US |
dc.identifier.issn | 1527-3350 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/38413 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=12447858&dopt=citation | en_US |
dc.description.abstract | The incidence of hepatocellular carcinoma (HCC) in the United States is increasing, but the clinical characteristics of American patients with HCC have not been well described. The aims of this study were to determine the etiology of liver disease and short-term outcome among HCC patients presenting to a single center in the United States. One hundred five consecutive patients with HCC were studied; mean age was 59 years, 67% were men, and 76% were non-Hispanic white. The most common etiology of liver disease was hepatitis C (51%) and cryptogenic cirrhosis (29%). Half of the patients with cryptogenic cirrhosis had histologic or clinical features associated with nonalcoholic fatty liver disease (NAFLD). Fifty-three (50%) patients had HCC detected during surveillance (group I), whereas the remaining patients had symptomatic tumors (group II). Group I patients had smaller tumors ( P = 0.01), were more likely to be eligible for surgical treatment ( P = 0.005), and had a better medican survival compared with patients in group II ( P = 0.001). Patients with cryptogenic cirrhosis were less likely to have undergone HCC surveillance and had larger tumors at diagnosis. In conclusion, hepatitis C and cryptogenic liver disease are the most common etiologies of diseases in our patients with HCC. NAFLD accounted for at least 13% of the cases. Patients who underwent surveillance had smaller tumors and were more likely to be candidates for surgical or local ablative therapies. Because of the increasing incidence of NAFLD, further studies are needed to determine the risk of HCC in patients with NAFLD. (H EPATOLOGY 2002;36:1349-1354). | en_US |
dc.format.extent | 591495 bytes | |
dc.format.extent | 3118 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.language.iso | en_US | |
dc.publisher | W.B. Saunders | en_US |
dc.publisher | Wiley Periodiocals, Inc. | en_US |
dc.subject.other | Life and Medical Sciences | en_US |
dc.subject.other | Hepatology | en_US |
dc.title | NAFLD may be a common underlying liver disease in patients with hepatocellular Carcinoma in the United States | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Internal Medicine and Specialties | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI ; University of Michigan, 3912 Taubman Center, Ann Arbor, MI 48109-0362.: fax: 734-936-7392 | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI | en_US |
dc.contributor.affiliationum | Department of Internal Medicine, Division of Gastroenterology, University of Michigan, Ann Arbor, MI | en_US |
dc.identifier.pmid | 12447858 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/38413/1/1840360609_ftp.pdf | en_US |
dc.identifier.doi | http://dx.doi.org/10.1053/jhep.2002.36939 | en_US |
dc.identifier.source | Hepatology | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.